Intralipid Emulsion
Product Images NDC 65219-537

19 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Intralipid (NDC 65219-537). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Intra-img-01.jpg (Intra Img 01)

Intra-img-01.jpg (Intra Img 01)
An instructional diagram showing an intravenous (I.V.) fat emulsion bag labeled Intralipid 30 g/100mL. The image highlights connectors A and B at the bottom of the bag, indicating points for fluid input and output lines for intravenous administration. The depiction is from Fresenius Kabi USA, LLC.*
FDA Label Image

Intra-img-02.jpg (Intra Img 02)

Intra-img-02.jpg (Intra Img 02)
An instructional diagram showing two hands handling a rectangular medical fluid bag with two labeled ports at the bottom, marked A and B.*
FDA Label Image

Intra-img-03.jpg (Intra Img 03)

Intra-img-03.jpg (Intra Img 03)
Illustrative diagram showing a person's hand preparing an intravenous fat emulsion by holding and potentially opening a vial or ampule. The image is instructional and relates to the preparation or administration of the product.*
FDA Label Image

Intra-img-04.jpg (Intra Img 04)

Intra-img-04.jpg (Intra Img 04)
An instructional illustration showing a hand holding an intravenous (IV) bag labeled as Intralipid I.V. Fat Emulsion 30 g/100 mL. The image depicts the connection of the IV bag's tubing to an infusion set, demonstrating the setup process for intravenous administration.*
FDA Label Image

Intra-graph-01.jpg (Intra Graph 01)

Intra-graph-01.jpg (Intra Graph 01)
A cumulative incidence function chart comparing Intralipid and 4-Oil Mixed Lipid over 84 study days, showing the number of subjects with event and censored. The solid line represents Intralipid (N=78) and the dashed line represents 4-Oil Mixed Lipid (N=83), with plotted censored data points. The chart includes patient counts at risk across study days with error bars reflecting uncertainties.*
FDA Label Image

Intra-struc-01.jpg (Intra Struc 01)

Intra-struc-01.jpg (Intra Struc 01)
Chemical structure diagram of the active ingredient in Intralipid I.V. Fat Emulsion 30 g/100 mL by Fresenius Kabi USA, LLC. The molecular structure shows multiple ester bonds and fatty acid components typical of an intravenous fat emulsion.*
FDA Label Image

Intra-struc-02.jpg (Intra Struc 02)

Intra-struc-02.jpg (Intra Struc 02)
Chemical structure diagram showing a molecular formula with carbon, oxygen, and hydrogen atoms, likely representing components of the active ingredient in Intralipid 30 g/100 mL intravenous fat emulsion.*
FDA Label Image

Intra-struc-03.jpg (Intra Struc 03)

Intra-struc-03.jpg (Intra Struc 03)
Chemical structure of the active ingredient in Intralipid 30 g/100 mL intravenous emulsion, showing a complex organic molecule with multiple carbon chains and functional groups consistent with a fat emulsion ingredient.*
FDA Label Image

Intra-struc-04.jpg (Intra Struc 04)

Intra-struc-04.jpg (Intra Struc 04)
Chemical structure diagram showing the molecular structure of the active ingredient in Intralipid I.V. Fat Emulsion 30 g/100 mL by Fresenius Kabi USA, LLC. The structure depicts a complex fatty acid chain typical of intravenous fat emulsions.*
FDA Label Image

Intra-struc-05.jpg (Intra Struc 05)

Intra-struc-05.jpg (Intra Struc 05)
Chemical structure diagram showing a long-chain fatty acid, consistent with the active ingredient in Intralipid I.V. Fat Emulsion 30 g/100mL by Fresenius Kabi USA, LLC.*
FDA Label Image

Intra-struc-06.jpg (Intra Struc 06)

Intra-struc-06.jpg (Intra Struc 06)
Chemical structure of the active ingredient in Intralipid I.V. Fat Emulsion 30 g/100mL by Fresenius Kabi USA, LLC. The structure depicts a fatty acid molecule with multiple double bonds and hydrocarbon chains, representative of the lipid components in the emulsion.*
FDA Label Image

Intra-struc-07.jpg (Intra Struc 07)

Intra-struc-07.jpg (Intra Struc 07)
Chemical structure of the active ingredient in Intralipid I.V. Fat Emulsion 30 g/100 mL by Fresenius Kabi USA, LLC. The structure shows a long hydrocarbon chain with a terminal carboxyl group, characteristic of a fatty acid component in the emulsion.*
FDA Label Image

Intra-struc-08.jpg (Intra Struc 08)

Intra-struc-08.jpg (Intra Struc 08)
Chemical structure diagram of the active ingredient in the product Intralipid I.V. Fat Emulsion 30 g/100mL by Fresenius Kabi USA, LLC. The structure shows a molecular formula with labeled chemical bonds and groups typically found in a fat emulsion.*
FDA Label Image

Intra-struc-09.jpg (Intra Struc 09)

Intra-struc-09.jpg (Intra Struc 09)
Chemical structure of the active ingredient depicted in the image, showing a triglyceride molecule with three fatty acid chains attached to a glycerol backbone. This structure corresponds to the lipid component typical of I.V. fat emulsions such as Intralipid.*
FDA Label Image

Intra-struc-10.jpg (Intra Struc 10)

Intra-struc-10.jpg (Intra Struc 10)
Chemical structures of phosphatidylcholine and phosphatidylethanolamine, shown as molecular diagrams with labeled chemical groups and bonds. These structures correspond to components commonly found in lipid emulsions.*
FDA Label Image

Intra-struc-11.jpg (Intra Struc 11)

Intra-struc-11.jpg (Intra Struc 11)
Chemical structure diagram showing a molecule with carbon, hydrogen, and hydroxyl groups, likely representing a component related to the product Intralipid I.V. Fat Emulsion.*
FDA Label Image

Intra-img-05.jpg (Intra Img 05)

FDA Label Image

Intra-label-01.jpg (Intra Label 01)

Intra-label-01.jpg (Intra Label 01)
Intralipid 30% 500 mL emulsion for intravenous use, a 30% I.V. fat emulsion. The label indicates it is a pharmacy bulk package not for direct infusion, containing soybean oil, phospholipids from powdered egg yolk, glycerin, and water for injection. Manufactured by Fresenius Kabi USA, LLC, Uppsala, Sweden.*
FDA Label Image

Intra-label-02.jpg (Intra Label 02)

Intra-label-02.jpg (Intra Label 02)
Label for Intralipid 30%, a 30% I.V. Fat Emulsion for intravenous use in a 500 mL pharmacy bulk package (12 x 500 mL). Contains soybean oil 30 g per 100 mL, phospholipids from powdered egg yolk, glycerin, and water for injection. Manufactured by Fresenius Kabi USA, LLC, with storage instructions and warnings. Includes barcodes and lot/expiration information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.